Neoadjuvant Treatment of Breast Cancer

NCT05131893 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen
DRUG: Goserelin
DRUG: Letrozole 2.5Mg Tab
DRUG: Epirubicin
DRUG: cyclophosphamide
DRUG: Docetaxel
DRUG: paclitaxel
DRUG: trastuzumab
DRUG: pertuzumab
DRUG: Capecitabine

Sponsor

National Institute of Oncology, Hungary